Building a patient group with Crohn disease or ulcerative colitis to predict outcomes
Builds a cohort of people with Crohn disease or ulcerative colitis to predict treatment response.
Key facts
- Who runs it
- Seoul National University Hospital
- Where
- Seoul, South KoreaSee the site
- Trial code
- Registry title
- Research for the Precision Medicine in the Treatment of Inflammatory Bowel Disease
- Status
- Enrolling by invitation
- People taking part
- 2,000 people, planned
- Started
- 20 Jan 2021
- Expected to end
- 31 Dec 2028
- Type of study
- Observational
- Record updated
- 15 September 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The study is looking for people aged 10 or older with inflammatory bowel disease (Crohn disease or ulcerative colitis), newly diagnosed or already in follow-up.
- Age
- 10 years or older
- Sex
- All sexes
- Disease stage
- Inflammatory bowel disease, either newly diagnosed or under follow-up monitoring
- Earlier treatment
- Anyone with a history of cancer treatment cannot join.
Main reasons for not taking part
- Diagnosed with cancer or has a history of cancer treatment
- Under 10 years old
- The medical team may decide that a person cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Patients aged 10 years or older who have been newly diagnosed with inflammatory bowel disease or are under follow-up monitoring
Who cannot take part
- Patients diagnosed with cancer or with a history of cancer treatment
- Infants and young children under the age of 10
- Participation may be restricted at the discretion of the medical team
Where in South Korea
- Seoul National University HospitalSeoul, South KoreaEnrolling by invitation
About the trial
What the trial wants to find out
This study aims to establish an integrated cohort of patients with inflammatory bowel disease (IBD) from Seoul National University Hospital, Seoul National University Boramae Medical Center, and Seoul National University Bundang Hospital. Through this cohort, we seek to develop a prognostic prediction model for IBD patients and a predictive model for therapeutic responses to biologic agents and small molecule therapies.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Convergence Research Platform for the Precision Medicine in the Treatment of Inflammatory Bowel Disease
- Plain-language title
- Building a patient group with Crohn disease or ulcerative colitis to predict outcomesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 15 September 2025